| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |